Australian psychedelic-assisted psychotherapy trials for treatment-resistant depression

Record summary

Australian clinical research groups have investigated psilocybin-assisted psychotherapy and related psychedelic interventions for depression and other psychiatric conditions. These trials matter for consciousness research because they operationalise mystical experience, ego dissolution, emotional insight and therapeutic change under controlled conditions. The leads should be treated as trial families rather than one assumed result: protocols, doses, psychotherapy models and outcome measures differ. Small samples, expectancy, unblinding and therapist allegiance complicate interpretation of both benefits and adverse experiences.